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Abstract
Background: Inflammatory bowel diseases are consequence of an intestinal homeostasis breakdown in which innate
immune dysregulation is implicated. Toll-like receptor (TLR)2 and TLR4 are immune recognition receptors expressed in
the intestinal epithelium, the first physical-physiological barrier for microorganisms, to inform the host of the presence of
Gram-positive and Gram-negative organisms. Interleukin (IL)-10 is an essential anti-inflammatory cytokine that contributes
to maintenance of intestinal homeostasis.
Aim: Our main aim was to investigate intestinal IL-10 synthesis and release, and whether TLR2 and TLR4 are determinants of
IL-10 expression in the intestinal tract.
Methods: We used Caco-2 cell line as an enterocyte-like cell model, and also ileum and colon from mice deficient in TLR2,
TLR4 or TLR2/4 to test the involvement of TLR signaling.
Results: Intestinal epithelial cells are able to synthesize and release IL-10 and their expression is increased after TLR2 or
TLR4 activation. IL-10 regulation seems to be tissue specific, with IL-10 expression in the ileum regulated by a compensation
between TLR2 and TLR4 expression, whereas in the colon, TLR2 and TLR4 affect IL-10 expression independently.
Conclusions: Intestinal epithelial cells could release IL-10 in response to TLR activation, playing an intestinal tissue-
dependent and critical intestinal immune role.
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Key summary
1. Summarize the established knowledge on this subject.
. Intestinal Toll-like receptors (TLRs) are immune receptors responsible for the recognition of luminal
microorganisms, causing a release of cytokines.
. Interleukin (IL)-10 is a critical anti-inflammatory cytokine, essential for intestinal homeostasis.
. However, little is known about the relation between intestinal IL-10 and TLRs.
2. What are the significant and/or new findings of this study?
. TLR2 and 4 can regulate intestinal IL-10 expression in a tissue-specific way.
. Here we describe how IL-10 expression is mediated by TLR2 and 4 supporting the idea that intestinal
epithelial cells could play a role in innate immune response by IL-10 release and how microbiota could
interfere in intestinal homeostasis controlling IL-10 levels.
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Intestinal immunological activity is determinant in
homeostasis since it contributes to recognition and tol-
erance of the intestinal microbiota. Inappropriate muco-
sal immune responses, due to dysregulation of tolerance
to microbiota, contribute to the development and main-
tenance of inflammatory bowel disease (IBD).1
Intestinal epithelium is the first physical-physiologi-
cal barrier for microorganisms to interact with the host.
Intestinal epithelial cells have been well documented to
express Toll-like receptors (TLRs), which are immune
receptors responsible for the recognition both of micro-
biota and pathogens.2 TLRs develop an important
immunological activity for precise maintenance of
intestinal homeostasis,3,4 inducing the synthesis and
release of pro- and anti-inflammatory cytokines.2 In
recent years, several studies have demonstrated that
TLR2 and TLR4 may play an important role in intes-
tinal homeostasis as well as in inflammatory processes.
TLR2 recognizes Gram-positive bacteria, and requires
co-expression with TLR1 and TLR6 for their activa-
tion,5 whereas TLR4 recognizes lipopolysaccharide
(LPS) from Gram-negative bacteria.6
Interleukin-10 (IL-10) is an anti-inflammatory cyto-
kine synthesized mainly by immune cells, whose main
function is the inhibition both of immune activation
and cell death.7 IL-10 has a critical role in the tolerance
to self- and mucosal antigens;8,9 in fact, IL-10-deficient
mice spontaneously develop intestinal inflammation, in
part due to defective hyporesponsiveness to micro-
biota.10 In addition, IL-10 modulates enteroendocrine
activity.11 These effects reveal the essential contribution
of IL-10 to intestinal homeostasis.
The intestinal epithelium is a rich source of pro-
inflammatory cytokines12,13 where their imbalance is
related to several gastrointestinal pathologies such as
IBD.14 Despite the critical role of IL-10 and TLRs in
maintaining intestinal homeostasis, little is known about
IL-10 production in the intestinal epithelium and its pos-
sible interaction with TLR activity. Therefore, our aim
was, initially, to analyze IL-10 synthesis and release in
human intestinal epithelial cells (Caco-2 cells), and sec-
ondly to assess the role of TLR2 and TLR4 activation in
the regulation of epithelial IL-10 expression, by studying
the dynamics of IL-10 in the intestinal tract of mice defi-
cient in TLR2, TLR4 or both.
Methods
Cell culture
Culture conditions for the human enterocyte-like cell
line Caco-2/TC7 has been described elsewhere.15 The
experiments were carried out 14 days after seeding
(nine days after confluence), since previous results
have shown that Caco-2/TC7 cell differentiation and
expression levels are maximal at this time. Cells were
treated for 24 hours with culture medium free of fetal
bovine serum (FBS) containing either 5 mgml1
Pam3CSK4, 50ngml1 Pam2CSK4 (InvivoGen, San
Diego, CA, USA); or 30mgml1 LPS (E. coli 0111:B4)
(Sigma-Aldrich, St Louis, MO, USA), which are specific
ligands of TLR2/1, TLR2/6, or TLR4, respectively.
The concentrations used were chosen based on previous
studies of our group,3,4,16 that have been shown to affect
the activity of epithelial cells, demonstrating that cell
viability and integrity were not compromised.
Animals
The experiments were approved by the Ethics
Committee for Animal Experiments from Zaragoza
University (PI36/12). The care and use of animals
were performed in accordance with the Spanish Policy
for Animal Protection RD53/2013 and the European
Union Directive 2010/63/EU on the protection of ani-
mals used for scientific purposes. Inbred C57BL/10 and
mouse strains deficient for TLR2 (Tlr2–/–), TLR4
(Tlr4–/–) or both (Tlr2/4–/–) were kindly provided by
Marina Freudenberg from the Max-Planck-Institut
für Immunbiologie, Freiburg, Germany, and bred
at the Centro de Investigación y Tecnologı́a
Agroalimentaria (CITA, Zaragoza, Spain). The geno-
types were periodically checked as described by Pardo
et al.17 All mice were housed under specific pathogen-
free conditions on a 12-hour light/dark cycle with food
and water ad libitum. Mice of 10–12 weeks of age were
euthanized by cervical dislocation. Immediately after
death, the intestinal tract was removed and rinsed
with an ice-cold solution of NaCl 0.9%. Tissue samples
for RNA analysis were collected in RNAlater (Qiagen,
Hilden, Germany) and then stored at 80C. Samples
for protein analysis were immediately frozen and stored
at 80C.
RNA extraction, reverse transcription (RT),
polymerase chain reaction (PCR) and
real-time PCR
Total RNA was extracted from mice intestinal tissue
and Caco-2/TC7 cells with the RNeasy Mini Kit
(Qiagen), following the manufacturer’s instructions.
RNA (1 mg) was used as a template for first-strand
complementary DNA (cDNA) synthesis using
oligo(dT) primers and a reverse transcriptase (Life
Technologies, Carlsbad, CA, USA). IL-10, TLR2 and
TLR4 messenger RNA (mRNA) levels were measured
using SYBR green and specific primers (Table 1). Each
sample was run in triplicate and the mean cycle thresh-
old (Ct) was determined. Relative mRNA expression
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under each experimental condition was expressed
as Ct (¼Ctgene – Ctcalibrators), with GAPDH
and HPRT1 as housekeeping genes. The relative
gene expression levels were calculated as Ct¼
Ctcontrol – Cttreatment, and finally converted and
expressed as fold difference (¼2Ct).
Western blotting analysis
Preparation of homogenates from Caco-2/TC7 cells
and mouse intestinal samples has been described previ-
ously.3 Proteins were electrophoresed in 8% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) gels, and transferred to polyvinylidene
fluoride (PVDF) membranes by electroblotting. The
membranes were probed with rabbit polyclonal anti-
body anti-human IL-10 (1:5000) (ABF13, Millipore,
Billerica, MA, USA), rabbit monoclonal anti-mouse
TLR2 (1:1000) (ab108998) or rabbit polyclonal anti-
mouse TLR4 (1:1000) (ab13556) (Abcam, Cambridge,
UK). Signal was detected using a secondary antibody
coupled to horseradish peroxidase (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and ECL Plus
detection kit (GE Healthcare, Buckinghamshire, UK)
and visualized with VersaDocTM (Imaging System, Bio-
Rad, Hercules, CA, USA). The blots were reprobed
with goat polyclonal anti-b-actin, and protein/b-actin
ratio calculated in densitometric units with Quantity
One Analysis Software (Bio-Rad).
Enzyme-linked immunosorbent assay (ELISA)
Caco-2/TC7 cells and mouse intestinal explants (30mg)
were maintained in growth medium (Dulbecco
Modified Eagle Medium (DMEM) containing 10%
FBS, 10mM glutamine, 10mM HEPES, 100Uml1
penicillin and 100 mgml1 streptomycin) for 24 hours
at 37C in an atmosphere of 5% CO2. After 24 hours
of incubation, the medium was collected, centrifuged at
500 g for 8minutes, and aliquots were stored at 80C.
IL-10 concentration was measured by the correspond-
ing Human or Murine IL-10 ELISA Kit (Diaclone,
Besançon, France) in a DTX-880 Multimode detector
(Beckman Coulter, CA, USA).
Statistics
All results are expressed as the mean standard devi-
ation (SD), with n denoting the number of biological
samples used. Normal distribution was confirmed with
the D’Agostino-Pearson test. Statistical comparisons
were performed by one-way analysis of variance
(ANOVA) followed by the Bonferroni post host test
with a confidence interval of 95% (p< 0.05).
Statistical analysis was carried out with the computer-
assisted Prism GraphPad program (Prism version 5.00,
GraphPad Software, San Diego, CA, USA).
Results
IL-10 expression and release in Caco-2/TC7 cells:
Role of TLR2 and TLR4 activation
First, IL-10 expression (mRNA and protein) in Caco-2/
TC7 cells was analyzed. An amplification product of
expected size (96 bp) was obtained for IL-10 expression
upon RT-PCR, and IL-10 protein expression was
immunodetected as a band-sized 20 kDa in the cell
homogenate (Figure 1(a) and (b)).
The roles of TLR2 and TLR4 on IL-10 expression and
release in Caco-2/TC7 cells were analyzed in cells treated
for 24 hours with Pam3CSK4 (5mgml1) or Pam2CSK4
(50ngml1) (TLR2/1 or TLR2/6 ligands, respectively) or
with LPS (30mgml1) (TLR4 ligand) concentrations that
have been shown to affect the activity of epithelial
cells.3,4,16 The results show that the activation of TLR2
or TLR4 increased significantly both IL-10 mRNA levels
(Figure 1(c)) and IL-10 release (Figure 1(d)).
Table 1. Primers designed from human (h) or mice (m) sequences of the different genes analyzed by
polymerase chain reaction (PCR) and real-time-PCR.
Name Forward primer (50-30) Reverse primer (50-30)
Amplicon
size (bp)
hIL-10 GATGCCTTCAGCAGAGTGAA CCCAGGTAACCCTTAAAGTCC 96
hGADPH CATGACCACAGTCCATGCCATCACT TGAGGTCCACCACCCTGTTGCTGTA 461
hHPRT1 CTGACCTGCTGGATTACA GCGACCTTGACCATCTTT 256
mIL-10 GGTTGCCAAGCCTTATCGGA ACCTGCTCCACTGCCTTGCT 191
mTLR2 GCCACCATTTCCACGGACT GGCTTCCTCTTGGCCTGG 67
mTLR4 AGAAATTCCTGCAGTGGGTCA TCTCTACAGGTGTTGCACATGTCA 84
mGADPH AACGACCCCTTCATTGAC TCCACGACATACTCAGCAC 191
mHPRT1 CTGGTGAAAAGGACCTCTCGAA CTGAAGTACTCATTATAGTCAAGGGCAT 110
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IL-10 expression in the intestinal tract of Tlr2–/–,
Tlr4–/– and Tlr2/4–/– mice
To corroborate the role of TLR2 and TLR4 in IL-10
expression in the intestinal tract, we carried out the
analysis of IL10 expression in the ileum and colon of
Tlr2–/– and Tlr4–/– mice.
Our results show that the in ileum IL-10 mRNA
expression (Figure 2(a)) and release (Figure 2(b)) were
significantly increased both in Tlr2–/– and Tlr4–/– mice.
The colon of Tlr4–/– mice showed a similar increasing
pattern of IL-10 release and mRNA expression.
However, in the colon of Tlr2–/– mice, IL-10 mRNA
expression was increased (Figure 2(c)), but IL-10
release was significantly diminished (Figure 2(d)).
These findings are in line with previous studies that
demonstrated TLR2 and TLR4 share potential synergy
by crosstalk mechanisms to carry out cell responses;18,19
therefore, a cross-interaction between TLR2 and TLR4
might explain our results on IL-10 expression and release
in the intestinal tract. To confirm this hypothesis, IL-10
expression was measured in the ileum and colon of Tlr2/
4–/– mice. IL-10 expression (mRNA level and release)
was significantly reduced in the ileum of Tlr2/4–/– mice,
corroborating the cooperative effect of TLR2 and TLR4
to modulate IL-10 expression (Figure 2(a) and (b)).
However, IL-10 release from Tlr2/4–/– mouse colon
was unchanged with respect to wild-type (WT) mice,
although IL-10 mRNA level was significantly increased
(Figure 2(c) and (d)).
Cross-regulation between TLR2 and TLR4
expression in mouse intestinal tract
To clarify the previous results, the expression of TLR2
or TLR4 was analyzed in the ileum and colon of Tlr4–/–
or Tlr2–/– mice, respectively. The results obtained in the
ileum show that TLR4 and TLR2 expression (mRNA
and protein) were significantly increased in both defi-
cient mice (Figure 3(a) and (b)), suggesting a compen-
satory effect between both receptors. However, the
results obtained in the colon did not show any alter-
ation of TLR2 or TLR4 expression in the correspond-
ing deficient mice (Figure 3(c) and (d)).
Discussion
The innate immune system plays an essential role in
intestinal homeostasis, developing several crucial regu-














































Figure 1. IL-10 expression in Caco-2/TC7 cells: Role of TLR2 and TLR4 activation. (a) IL-10 mRNA was detected in two independent
preparations. (b) IL-10 protein was analyzed by Western blotting (60 mg of protein), and a band with a size of 20 kDa was immunodetected.
(c) IL-10 mRNA expression in cells treated for 24 hours with Pam3CSK4 5 mg ml1 (TLR2/1), Pam2CSK4 50 ng ml1 (TLR2/6) or LPS
30 mg ml1 (TLR4). Results are expressed in arbitrary units and are the mean SD of four independent experiments (n ¼ 12). (d) IL-10
release in cells treated as in (c). Results are expressed in pg ml1 of IL-10 in culture medium as the mean SD of three independent
experiments (n¼ 21). **p< 0.01 and ***p< 0.001 compared with untreated cells (Control: (c)).
IL: interleukin; TLR: Toll-like receptor; mRNA: messenger RNA; LPS: lipopolysaccharide.
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deregulation of these mechanisms may be implicated in
intestinal pathologies such as IBD, in which a cytokine
imbalance and altered microbiota are present.
A number of cell types can produce IL-10, including
lymphocytes, monocytes, macrophages, mast cells,
keratinocytes, endothelial cells, neurons of the enteric
nervous system and intestinal epithelial cells.20
Intestinal macrophages are robust producers of IL-10,
but depend on the presence of commensal bacteria, and
the most steady-state macrophages do not express
TLRs. In contrast dendritic cells are not believed to
be major producers of IL-10 in the lamina propia.21
Interestingly, intestinal epithelial cells have been identi-
fied as the major cell type expressing IL-10 in the
normal intestine,22,23 which appears to be physiologic-
ally indispensable for epithelial homeostasis. This sug-
gests that in normal, non-inflammatory situations, the
intestinal epithelial cells would be the major source of
IL-10 production, due to being the major cell type
expressing IL-10, but also due to the elevated number
of these cells in the gut. IL-10 has been described as an
essential cytokine in maintaining intestinal homeosta-
sis24 and has been shown to be modulated by different
microorganism residing in the gut lumen.25 However,
the effect of TLR2 and TLR4, which recognize Gram-
positive and Gram-negative bacteria, respectively,
on IL-10 expression in the intestinal epithelium,
remained unknown.
Our results suggest that enterocytes may act as an
IL-10 source for intestinal epithelium that could be
increased by TLR2 and TLR4 activation. The role of
several TLRs in IL-10 expression has been previously
described in dendritic,26 T-regulatory cells18 and B
cells.27 Moreover, a recent study has concluded that
IL-10 expression in intestinal epithelial cells seemed to
be mediated by a crosstalk with macrophages involving
TLR4.23 In this way, another study using Caco-2 and
HT-29 cells has described that co-culture with patho-
genic bacteria increases IL-10 mRNA expression,
together with other anti- and pro-inflammatory cyto-
kines, but co-culture with commensal bacterial induces
a reduction of cytokines expression,28 suggesting differ-
ent ways of modulation as a function of the bacteria
specie and the TLR activated.
The present study has also analyzed the role of
TLR2 and TLR4 on IL-10 expression in the intestinal
tract. Surprisingly, in the ileum of Tlr2–/– or Tlr4–/–
mice, IL-10 mRNA level and IL-10 release increased;
however, in the colon, only Tlr4–/– mice followed the
same pattern for IL-10 expression as the ileum. Since
TLR2 or TLR4 activation was shown to increase IL-10
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Figure 2. Analysis of IL-10 expression and release in the ileum ((a), (b)) and colon ((c), (d)) from WT, Tlr2–/–, Tlr4–/–, and Tlr2/4–/– mice. IL-
10 mRNA in ileum (a) and colon (c). Relative quantification was performed in triplicate using comparative Ct (2Ct) of five animals, and
results are expressed as arbitrary units (WT¼ control¼ 1; mean SD). IL-10 release was measured from ileum (b) and colon (d) explants
incubated for 24 hours in growth medium; the results are calculated in IL-10 pg ml1 in medium as the mean SD of five animals.
**p< 0.01 and ***p< 0.001 compared with the corresponding values in WT.
IL: interleukin; WT: wild-type; mRNA: messenger RNA; Ct: cycle threshold.
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TLR-deficient mice did not get the expected results.
Nevertheless, a recent analysis in a biological approach
system has revealed that TLR2 and TLR4 share poten-
tial collaboration by crosstalk mechanisms to carry out
cell responses;19 therefore, a compensation between
TLR2 and TLR4 might explain our results on IL-10.
Our analysis of Tlr2–/– mice has shown that TLR4
expression is increased in the ileum, but unaltered in
the colon. Similarly, TLR2 expression in Tlr4–/– mice
was increased only in the ileum. Therefore, these results
suggest a possible compensation between TLR2 and
TLR4 expression in the ileum, but not in the colon.
The involvement of a cross-interaction between
TLR2 and TLR4 in the regulation of IL-10 expression
in the intestinal tract was confirmed by the significant
reduction of IL-10 expression obtained in the ileum of
Tlr2/4–/–mice. In agreement with these results, a similar
study has also described a compensation between
TLR2 and TLR4 to ensure a suitable immune response
in gastric epithelial cells.29 From our results, it may be
inferred that both TLR2 and TLR4 not only might
be able to stimulate IL-10 expression in the intestinal
epithelium, but in the ileum, may ensure this regulation
by a compensatory effect between both receptors. Thus,
in case of TLR2 dysfunction, TLR4 may lead to
an increase of IL-10 expression, and vice versa. These
results reveal that TLR2 and TLR4 may compensate
each other in the ileum, which may contribute to regu-
late IL-10 expression; however, in the colon, IL-10
could be individually modulated by TLR2 and TLR4,
but we cannot exclude other regulatory mechanisms
that could explain the non-altered secretion of IL-10
obtained in Tlr2/4–/–mice.
The analysis in the colon has indicated that TLR2
and TLR4 did not appear to modulate their expression








































































Figure 3. Modulation of TLR2 and TLR4 expression in the ileum ((a), (b)) and colon ((c), (d)) of deficient mice (Tlr2–/–and Tlr4–/–). TLR2 and
TLR4 mRNA level was measured in ileum (a) and colon (c) from WT, Tlr2–/–and Tlr4–/– mice. Relative quantification was performed in
triplicate using comparative Ct (2Ct) of five animals, and results are expressed as arbitrary units (WT¼ control¼ 1; mean SD). TLR2
and TLR4 protein level was measured in ileum (b) and colon (d) of WT, Tlr2–/–and Tlr4–/– mice. In the upper part of the graph, an
immunodetection of TLR2 and TLR4 is shown. In the lower part the quantitation of TLR4 and TLR2 protein level using b-actin as an internal
control of the protein load (TLR/actin ratio) was drawn. The results are expressed as densitometric units and are the mean SD of five
animals. **p< 0.01 and ***p< 0.001 compared with the corresponding values in WT.
IL: interleukin; TLR: Toll-like receptor; mRNA: messenger RNA; WT: wild-type; Ct: cycle threshold.
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collaborate in the IL-10 regulation. In fact, the mice
deficiency of either TLR2 or TLR4 increased IL-10
mRNA, and Tlr2/4–/– mice induced the same result.
IL-10 availability in the colon was reduced in Tlr2–/–
and increased in Tlr4–/– mice. These results could be
caused by using whole tissue; the proportion of different
cells (i.e. immune cells, muscular cells, neurons) may be
different between the ileum and colon, therefore the
TLR2-TLR4 interaction described in the ileum could
be masked by other types of cells in the colon.
Moreover, since the colon is the part of the intestinal
tract most exposed to microbiota, the levels of tolerance
to bacteria are different from in the ileum, and the colon
presents different TLR expression.30 Consequently, the
response induced by TLRs in IL-10 expression may
show a different pattern. Actually, it has been shown
that IL-10 mRNA is a constitutive transcript in many
cells, but the availability of its protein may be signifi-
cantly determined by post-transcriptional mechanisms
such as microRNA (miRNA) or may be regulated by
different TLRs.31,32
TLR2 and TLR4 are widely known for their role in
immune response activating pro-inflammatory cytokine
production by nuclear factor (NF)-kB. However, some
studies have described a TLR2 and TLR4 critical role
in intestinal homeostasis and in the prevention of
inflammation.33,34 The results of the present work con-
firm the role of TLR2 and TLR4 in intestinal inflam-
matory processes, by acting on IL-10 regulation from
the intestinal epithelial cells. Studies in patients suffer-
ing IBD have described alterations in both TLR2 and
TLR4 expression35 and a significant decrease in IL-10
levels,36 supporting our results. In addition, our study
has also demonstrated a compensation between TLR2
and TLR4, which may contribute to an essential
homeostatic role for preventing inflammation.
Overall, we have demonstrated that intestinal epithe-
lial cells could produce and release IL-10, and actively
take part in the immune response. This release appears
to be mediated by a compensation between TLR2 and
TLR4 expression in the ileum, to ensure the levels of
IL-10 in the gut. This work opens the possibility of an
immune role for intestinal epithelial cells and illustrates
how bacteria in the gut may modulate intestinal activity
through TLRs. In addition, the tissue-dependent
modulation exerted by TLR2 and TLR4 on IL-10
might explain why certain IBDs are restricted to differ-
ent regions of the digestive tract.
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